Revlimid And Prednisone Followed By Revlimid, Melphalan And Prednisone In Multiple Myeloma Patients

Clinical trial NCT01160107 · COMPLETED

Trial details

NCT number: NCT01160107
Sponsor: Fondazione EMN Italy Onlus
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2008-07-01
Primary completion: 2012-08-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.